A client is brought for emergency care for symptoms that developed after ingesting mescaline, a hallucinogen. Which action will the nurse make a priority when caring for the client?

Choice A reason: Reducing environmental stimuli is the priority nursing action for a client experiencing adverse effects from mescaline intoxication. Mescaline is a naturally occurring phenethylamine hallucinogen derived from the peyote cactus (Lophophora williamsii) that produces profound perceptual distortions, visual and auditory hallucinations, ego dissolution, emotional lability, paranoia, and intense sympathomimetic arousal through agonism at 5-HT2A serotonin receptors. In this state, excessive environmental stimulation — including bright lights, loud sounds, and physical crowding — significantly amplifies perceptual distortion, fear, and agitation, potentially precipitating a "bad trip" with paranoid ideation, panic, and behavioral dyscontrol. Minimizing sensory input creates a calming, low-stimulus environment that reduces the intensity of hallucinogenic experiences and facilitates de-escalation. Choice B reason: Instructing or attempting to prevent a client from falling asleep during mescaline intoxication is not a recognized or clinically indicated nursing intervention. Hallucinogens such as mescaline do not typically cause respiratory depression or airway compromise during intoxication at standard doses, making sleep prevention unnecessary from a physiological safety standpoint. Keeping a client awake against their natural physiological drive may increase agitation, resistance, and behavioral unpredictability. The priority is management of the psychological and sympathomimetic effects of the drug, not prevention of sleep. Choice C reason: Providing a caffeinated beverage is contraindicated in the management of mescaline intoxication. Mescaline produces significant sympathomimetic stimulation through serotonergic and adrenergic pathways, resulting in tachycardia, hypertension, hyperthermia, and mydriasis. Caffeine, as an adenosine receptor antagonist and phosphodiesterase inhibitor, would further increase sympathetic nervous system activity, potentially worsening tachycardia, elevating blood pressure, increasing anxiety, and exacerbating agitation in an already physiologically stimulated state. Administering caffeine to a client experiencing stimulant-like toxicity is clinically inappropriate and potentially harmful. Choice D reason: Applying a warming blanket is not a priority intervention for mescaline intoxication and may in fact be contraindicated. Mescaline, like other serotonergic hallucinogens, can produce hyperthermia due to increased metabolic rate, serotonin receptor-mediated central thermogenic effects, and psychomotor agitation. Applying a warming blanket to a client who may already be hyperthermic would risk further elevating core body temperature, potentially contributing to heat stroke, rhabdomyolysis, or other thermogenic complications. Temperature management in mescaline intoxication should be directed at cooling, not warming.